Arkolith/Insider Trading/ELYM/Form 4

Brennan Aoife

President and CEO, DirectorEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jun 27, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 27, 2024Grant(A)550K—$0550K
Jun 27, 2024Grant(A)275K—$0275K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-078688) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML